EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO‐1/NLRP3 pathway

Gang Jin, Wei Xu, Huilin Tang, Yaying Cui, Han Zhang

Immunity, Inflammation and Disease · 2024-02 · 12 (2)

DOI: 10.1002/iid3.1195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 27.02.2024. Verfasst von Gang Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China. Hauptthemen laut MEDLINE: Curcumin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan Project of Taizhou, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this thesis is to evaluate the effect of bisdemethoxycurcumin (BDMC) on osteoarthritis (OA) and comprehensively evaluate the role of the Nuclear Factor erythroid 2‐Related Factor 2 (Nrf2) signalling pathway in chondrocytes.

Method

In our study, we treated chondrocytes with BDMC in an in vitro chondrocyte assay and measured its influence on extracellular matrix (ECM) expression, downstream heme oxygenase‐1 (HO‐1) and NOD‐like receptor thermal protein domain associated protein 3 (NLRP3) levels.

Results

Our study indicates that BDMC significantly activates the Nrf2 signaling pathway in chondrocytes in vitro. Furthermore, the expression of matrix metalloproteinase 3, interleukin 1β, recombinant a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and (ADAMTS)5 was significantly suppressed by BDMC.

Conclusion

This study confirms the potential for BDMC to activate the Nrf2/HO‐1/NLRP3 signalling pathway and alleviate OA symptoms. Therefore, BDMC is a promising therapeutic agent for OA that offers new insights and treatment methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminHumansChondrocytesNF-E2-Related Factor 2Heme Oxygenase-1NLR Family, Pyrin Domain-Containing 3 ProteinDiarylheptanoidsInflammationCartilage

Stichwörter der Autor:innen

Nrf2bisdemethoxycurcumincartilageosteoarthritispyroptosis

Substanzen

CurcuminNF-E2-Related Factor 2Heme Oxygenase-1NLR Family, Pyrin Domain-Containing 3 ProteinDiarylheptanoids

Autor:innen und Institutionen

  • Department of Orthopedics, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.

Förderung

  • Science and Technology Plan Project of Taizhou
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Jin, G., Xu, W., Tang, H., Cui, Y., & Zhang, H. (2024). Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO‐1/NLRP3 pathway. Immunity, Inflammation and Disease, 12(2). https://doi.org/10.1002/iid3.1195

Vancouver

Jin G, Xu W, Tang H, Cui Y, Zhang H. Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO‐1/NLRP3 pathway. Immunity, Inflammation and Disease. 2024;12(2). doi:10.1002/iid3.1195

BibTeX
@article{Jin2024,
  author = {Jin, Gang and Xu, Wei and Tang, Huilin and Cui, Yaying and Zhang, Han},
  title = {Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO‐1/NLRP3 pathway},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {2},
  doi = {10.1002/iid3.1195}
}
Kostenlos starten →